Antonio Jesús Martínez-Ortega

Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff

Ana R. Romero-Lluch, J.I. Cuenca-Cuenca, Raquel Guerrero-Vázquez et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 59 citations

Positron Emission Tomography, Neuro-oncology, Carcinoembryonic Antigen Cutoff +6

Quantification of an intact monoclonal antibody, rituximab, by (RP)HPLC/DAD in compliance with ICH guidelines

Natalia Navas, Agustín Herrera, Antonio Jesús Martínez-Ortega et al. · Analytical and Bioanalytical Chemistry · 2013 · 42 citations

Immunohematology, Allergy, Autoimmune Disease +13

Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of the intact monoclonal antibody cetuximab

Antonio Jesús Martínez-Ortega, Agustín Herrera, Antonio Salmerón‐García et al. · Journal of Pharmaceutical Analysis · 2015 · 32 citations · Full text

Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles

José G. Hernández‐Jiménez, Antonio Jesús Martínez-Ortega, Antonio Salmerón‐García et al. · International Journal of Biological Macromolecules · 2018 · 29 citations

Long-term Stability Tests, Immunocytochemical Technique, Autoimmune Disease +13

Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study

Antonio Jesús Martínez-Ortega, Agustín Herrera, Antonio Salmerón‐García et al. · International Journal of Biological Macromolecules · 2018 · 27 citations

Translational Medicine, Long-term Stability Study, Pharmacology +2